Department VI, Cardiology, University of Medicine and Pharmacy "Victor Babes" Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.
Department VII, Internal Medicine II, Discipline of Cardiology, University of Medicine and Pharmacy "Victor Babes" Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.
Medicina (Kaunas). 2021 May 3;57(5):441. doi: 10.3390/medicina57050441.
: COVID-19 pandemic severely impacted public health services worldwide, determining a significant decrease of elective cardiovascular (CV) procedures, especially in patients with associated chronic diseases such as diabetes mellitus (DM). : This study was first started in 2019 in the western of Romania, to analyze the differences regarding the implantations of intra-cardiac devices such as permanent pacemakers (PPM), cardiac resynchronization therapy (CRT), or implantable cardioverter-defibrillators (ICD) in 351 patients with and without DM and the situation was reanalyzed at the end of 2020. : of the first 351 patients with and without DM. 28.20% of these patients had type 2 DM ( = 0.022), exceeding more than twice the prevalence of DM in the general population (11%). Patients with DM were younger ( = 0.022) and required twice as often CRT ( = 0.002) as non-diabetic patients. The state of these procedures was reanalyzed at the end of 2020, a dramatic decrease of all new device implantations being observed, both in non-diabetic and in patients with type 2 DM (79.37%, respectively 81.82%). : COVID-19 pandemic determined a drastic decrease, with around 75% reduction of all procedures of new intra-cardiac devices implantation, both in non-diabetics, this activity being reserved mostly for emergencies.
: COVID-19 大流行严重影响了全球的公共卫生服务，导致心血管（CV）择期手术显著减少，尤其是在患有糖尿病等相关慢性病的患者中。 : 本研究于 2019 年在罗马尼亚西部首次开展，旨在分析 351 例有和无糖尿病患者中心脏内植入设备（如永久性起搏器[PPM]、心脏再同步治疗[CRT]或植入式心脏复律除颤器[ICD]）植入的差异，并于 2020 年底重新分析了这一情况。 : 351 例有和无糖尿病患者中，有 28.20%的患者患有 2 型糖尿病（ = 0.022），超过普通人群中糖尿病患病率的两倍以上（11%）。糖尿病患者更年轻（ = 0.022），且更常需要 CRT（ = 0.002）。2020 年底重新分析了这些患者的情况，观察到所有新设备植入术都大幅减少，无论是非糖尿病患者还是 2 型糖尿病患者（分别减少 79.37%和 81.82%）。 : COVID-19 大流行导致所有新植入心脏内设备的程序急剧减少，约减少了 75%，无论是非糖尿病患者，这种活动主要保留用于紧急情况。
